BNP Paribas Financial Markets’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$165K Buy
42,941
+30,924
+257% +$127K ﹤0.01% 4134
2025
Q4
$44.6K Sell
12,017
-91,749
-88% -$787K ﹤0.01% 4738
2025
Q3
$1.47M Buy
103,766
+101,703
+4,930% +$1.59M ﹤0.01% 2855
2025
Q2
$39.6K Buy
2,063
+2,034
+7,014% +$31.8K ﹤0.01% 4346
2025
Q1
$321 Sell
29
-2
-6% -$24 ﹤0.01% 5172
2024
Q4
$515 Buy
+31
New +$387 ﹤0.01% 5168

Other funds holding OM

BNP Paribas Financial Markets's OM Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Outset Medical (OM) stake by 257% in Q1 2026, buying an estimated $127K and bringing the position to 42,941 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #4134.

BNP Paribas Financial Markets first reported a position in OM in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.47M in Q3 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • BNP Paribas Financial Markets held 42,941 shares of Outset Medical worth $165K as of Q1 2026.
  • BNP Paribas Financial Markets bought 30,924 Outset Medical shares in Q1 2026, an estimated $127K.
  • Outset Medical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4134 holding.
  • BNP Paribas Financial Markets first reported a position in Outset Medical in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Outset Medical position peaked at $1.47M in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.